Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

1.65USD
23 Apr 2018
Change (% chg)

$-0.01 (-0.60%)
Prev Close
$1.66
Open
$1.67
Day's High
$1.67
Day's Low
$1.64
Volume
6,782
Avg. Vol
121,079
52-wk High
$3.78
52-wk Low
$1.09

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.25 -0.237
Sep '17 0.25 -0.311
Jun '17 0.00 -0.320
Mar '17 0.00 -0.412
FY 2016 Dec '16 0.00 -0.469
Sep '16 0.00 -0.543
Jun '16 0.00 -0.614
Mar '16 0.00 -0.614
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 2 0.12 0.25 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.72
Earnings (per share)
Quarter Ending Jun-18 3 -0.21 -0.17 -0.24 -0.55
Quarter Ending Sep-18 3 -0.22 -0.20 -0.23 -0.57
Year Ending Dec-18 3 -0.85 -0.77 -0.92 -1.77
Year Ending Dec-19 3 -1.19 -0.71 -1.64 -1.99
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.04 32.78
P/E High - Last 5 Yrs. -- 284.68 45.94
P/E Low - Last 5 Yrs. -- 95.75 24.95
Beta -- 0.75 0.80
Price to Sales (TTM) 96.40 136.40 7.08
Price to Book (MRQ) 3.31 19.34 5.00
Price to Tangible Book (MRQ) 4.09 24.06 6.75
Price to Cash Flow (TTM) -- 122.96 25.60
% Owned Institutions 35.08 11.18 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.55
Dividend Yield - 5 Year Avg -- 0.20 0.74
Dividend 5 Year Growth Rate -- 1.94 3.92
Payout Ratio(TTM) -- 9.18 20.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 103.99 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 80.63 10.85
Sales - 5 Yr. Growth Rate -- 33.87 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 49.61 -66.82 22.25
EPS (TTM) vs TTM 1 Yr. Ago 42.87 -- --
EPS - 5 Yr. Growth Rate -- 47.44 10.24
Capital Spending - 5 Yr. Growth Rate -30.83 45.48 10.39

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.53
Current Ratio (MRQ) 2.90 5.97 3.62
LT Debt to Equity (MRQ) 0.00 23.32 11.28
Total Debt to Equity (MRQ) 21.02 25.75 13.94
Interest Coverage (TTM) -59.76 -181.71 30.08

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 36.28 53.98
Gross Margin - 5 Yr. Avg. -- 55.36 52.10
EBITD Margin (TTM) -5,358.00 -- --
EBITD - 5 Yr. Avg -26,528.40 -149.35 15.94
Operating Margin (TTM) -5,418.80 -564.83 4.32
Operating Margin - 5 Yr. Avg. -26,822.20 -161.27 11.31
Pre-Tax Margin (TTM) -5,472.80 -537.64 4.97
Pre-Tax Margin - 5 Yr. Avg. -27,211.20 -168.32 11.62
Net Profit Margin (TTM) -5,472.80 -526.60 1.58
Net Profit Margin - 5 Yr. Avg. -27,211.20 -168.70 7.94
Effective Tax Rate (TTM) -- -0.44 31.27
Effective Tax Rate - 5 Yr. Avg. -- 18.13 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,918,133 819,537,692
Net Income/Employee (TTM) -- 754,796 96,346,718
Receivable Turnover (TTM) -- 6.24 5.57
Inventory Turnover (TTM) -- 2.37 3.45
Asset Turnover (TTM) 0.02 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -94.19 -0.77 10.55
Return on Assets - 5 Yr. Avg. -83.24 0.69 11.58
Return on Investment (TTM) -125.05 -0.74 13.21
Return on Investment - 5 Yr. Avg. -99.87 4.20 14.99
Return on Equity (TTM) -133.88 -2.80 15.01
Return on Equity - 5 Yr. Avg. -- -0.05 16.27
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 35.08%
# of Holders: 31
Total Shares Held: 10,186,312
3 Mo. Net Change: 935,321
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 2
# Reduced Positions: 3
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.